Staying current with the most recent advancements in the treatment for upper tract urothelial carcinoma (UTUC) is essential for your practice. Participate in this dynamic Clinical Case Challenge to enhance your understanding of the latest real-world evidence concerning novel therapies for low-grade UTUC (LG-UTUC). This engaging activity guides you in therapy selection and sequencing and adverse event management for a patient with UTUC. You can also compare your knowledge and decision-making skills with those of your peers! After completing the activity, be sure to download a concise summary of the key evidence that supports these practices.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/evidence-based-treatment-management-low-grade-utuc-novel-therapies
- Start Date: 2024-08-30 05:00:00
- End Date: 2024-08-30 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Urogen Pharma, Inc. - Amount: 31583.33 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Infectious Disease, Internal Medicine
Subscribe
Login
0 Comments
Oldest